Analysis of Risk Factors for the Development of Bronchiolitis Obliterans Syndrome
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Chronic rejection after lung transplantation, manifesting as bronchiolitis obliterans syndrome (BOS), has become the dominant challenge to long-term patient and graft survival. In order to elucidate risk factors for development of BOS we utilized the 1995 revision of the working formulation for the classification of lung allograft rejection (), and devised a quantitative method to retrospectively study lung transplant biopsies from all patients who survived at least 90 d. All transbronchial biopsies were regraded 0 to 4 for acute perivascular rejection and lymphocytic bronchitis/bronchiolitis (LBB), and the grades were totaled over a period of time to give two scores, respectively, for each patient. Also examined were timing of acute rejection and LBB episodes and decreased immunosuppression defined as two or more cyclosporine A levels < 200 ng/ml. Sixty-six patients with BOS and 68 with no BOS (NBOS) satisfied our criteria for inclusion in the study. Demographics including age, sex, and primary diagnoses were similar. The mean perivascular score for BOS was 6.2 over a mean follow-up of 822 d (range, 113 to 2,146) compared with 3.2 for NBOS over 550 d (range, 97 to 1,734) mean follow-up. Airway scores were 5.3 and 1.7, respectively, for the same follow-up periods. There was no correlation between length of follow-up and rejection or LBB scores, although mean length of follow-up for the two groups was significantly different. Late acute rejection and LBB were significantly associated with BOS as was decreased immunosuppression. In addition to perivascular rejection, LBB, late acute rejection, and decreased immunosuppression are significant risk factors for the development of BOS. Analysis of the current data leads us to believe that LBB, in the absence of infection, is in fact a manifestation of acute rejection, with similar implications for graft function as acute perivascular rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,665
Yousem, S. A., Berry, G. J., Cagle, P. T., Chamberlain, D. W., Husain, A. N., Hruban, R. H., Marchevsky, A. M., Ohori, N. P., Ritter, J. M., Stewart, S., et al. (1996) · PubMed · Cited by 842
Self-citationCooper, J. D., Billingham, M. E., Egan, T. M., Hertz, M. I., Higenbottam, T., Lynch, J., Mauer, J., Paradis, I. L., Patterson, G. A., & Smith, C. R. (1993) · PubMed · Cited by 723
THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG-TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2
MATAS, A. J., GILLINGHAM, K. J., PAYNE, W. D., & NAJARIAN, J. S. (1994) · Transplantation · doi:10.1097/00007890-199403270-00015 · Cited by 435
Obliterative bronchiolitis after lung and heart-lung transplantation
Bando, K., Paradis, I. L., Similo, S., Konishi, H., Komatsu, K., Zullo, T. G., Yousem, S. A., Close, J. M., Zeevi, A., Duquesnoy, R. J., et al. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(05)80003-0 · Cited by 418
Risk factors for the development of obliterative bronchiolitis after lung transplantation.
Girgis, R. E., Tu, I., Berry, G. J., Reichenspurner, H. C., Valentine, V. G., Conte, J. V., Ting, A., Johnstone, I., Miller, J. L., Robbins, R. C., et al. (1996) · PubMed · Cited by 283
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
Sundaresan, S., Trulock, E. P., Mohanakumar, T., Cooper, J. D., & Patterson, G. A. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00751-6 · Cited by 190
Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation
Bando, K., Paradis, I. L., Komatsu, K., Konishi, H., Matsushima, M., Keenan, R. J., Hardesty, R. L., Armitage, J. M., & Griffith, B. P. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70419-1 · Cited by 167
Improved results of lung transplantation for patients with cystic fibrosis
Egan, T. M., Detterbeck, F. C., Mill, M. R., Paradowski, L. J., Lackner, R. P., Ogden, W. D., Yankaskas, J. R., Westerman, J. H., Thompson, J. T., Weiner, M. A., et al. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70383-7 · Cited by 112
Lymphocytic Bronchitis/Bronchiolitis in Lung Allograft Recipinets
Yousem, S. A. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199305000-00008 · Cited by 111
HLA-CLASS II ANTIGEN EXPRESSION IN HUMAN HEART-LUNG ALLOGRAFTS
Yousem, S. A., Curley, J. M., Dauber, J. H., Paradis, I. L., RABINOWICH, H., Zeevi, A., Duquesnoy, R. J., Dowling, R. D., Zenati, M. A., Hardesty, R., et al. (1990) · Transplantation · doi:10.1097/00007890-199005000-00030 · Cited by 59
Cited by
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
Estenne, M., Maurer, J. R., Boehler, A., Egan, J. J., Frost, A., Hertz, M., Mallory, G. B., Snell, G. I., & Yousem, S. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00398-4 · Cited by 1,274
Meyer, K. C., Raghu, G., Verleden, G. M., Corris, P. A., Aurora, P., Wilson, K. C., Brozek, J., Glanville, A. R., & the ISHLT/ATS/ERS BOS Task Force Committee (2014) · European Respiratory Journal · doi:10.1183/09031936.00107514 · Cited by 555
Risk factors for bronchiolitis obliterans: a systematic review of recent publications
Sharples, L. D., McNeil, K., Stewart, S., & Wallwork, J. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(01)00360-6 · Cited by 348
Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death
Khalifah, A. P., Hachem, R. R., Chakinala, M. M., Schechtman, K. B., Patterson, G. A., Schuster, D. P., Mohanakumar, T., Trulock, E. P., & Walter, M. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1359oc · Cited by 328
A Randomized Controlled Trial of Tacrolimus Versus Cyclosporine After Lung Transplantation
Hachem, R. R., Yusen, R. D., Chakinala, M. M., Meyers, B. F., Lynch, J. P., Aloush, A. A., Patterson, G. A., & Trulock, E. P. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.07.027 · Cited by 160
Metadata
- Authors
- HUSAIN, A. N., SIDDIQUI, M. T., HOLMES, E. W., CHANDRASEKHAR, A. J., McCABE, M., RADVANY, R., & GARRITY, E. R.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-03-01
- Volume
- 159
- Issue
- 3
- Pages
- 829-833
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2011415380
- Cited by
- 267
- References
- 11
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.